GRFS (GRFS) Stock Price & Analysis
GRFS (GRFS) rose 0.53% to USD 7.58 as of July 25, 2026 at 03:50 UTC, according to Nexqual real-time market data.
GRFS last closed at USD 7.54; the session ranged USD 7.56–7.66 on volume of 451,865 shares. Market capitalization is $5.16B, with a 52-week range of USD 6.96–11.14 (NMS). Source: Nexqual, July 25, 2026 at 03:50 UTC.
Key Statistics (as of July 25, 2026 at 03:50 UTC)
| Price | USD 7.58 |
|---|---|
| Change | ▲ 0.53% (up) |
| Previous Close | USD 7.54 |
| Open | USD 7.56 |
| Day Range | USD 7.56 – 7.66 |
| 52-Week Range | USD 6.96 – 11.14 |
| Volume | 451,865 shares |
| Market Cap | $5.16B |
| Exchange | NMS |
Technical Analysis (GRFS)
Nexqual's technical model rates GRFS "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 03:50 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.92 (neutral) |
| vs SMA50 | Above (USD 7.52) |
| MACD | 0.04 (positive) |
Analyst Ratings (GRFS)
Wall Street analysts rate GRFS "Buy" based on 2 analysts, with a mean price target of USD 10.87 (range USD 10–11.73), per Nexqual as of July 25, 2026 at 03:50 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 10.87 |
| High Target | USD 11.73 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (GRFS)
| Next Earnings Date | 2026-07-28 |
|---|---|
| EPS Estimate | USD 0.28 |
| Revenue Estimate | $1.89B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-06-30 | USD 0.22 vs est 0.28 ▼ miss |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Financials & Fundamentals (GRFS)
| Total Revenue | $7.44B |
|---|---|
| Revenue Growth (YoY) | -4.80% |
| Gross Margin | +38.36% |
| Operating Margin | +16.47% |
| Profit Margin | +5.58% |
| ROE | +6.13% |
| Debt / Equity | 123.22 |
| Current Ratio | 2.47 |
| Total Cash | $702.00M |
| Total Debt | $9.67B |
| Free Cash Flow | $887.54M |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Financial Health Score (GRFS)
Nexqual rates GRFS's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:50 UTC.
| Growth | Mixed — Revenue +4.3% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 38%, operating 16% |
| Balance Sheet | Mixed — $702M cash vs $9.67B debt |
| Cash Flow | Solid — FCF $888M, 12% margin |
| Efficiency | Mixed — ROE 6%, ROA 4.2% |
Ownership (GRFS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +58.23% |
| Shares Outstanding | 258.22M |
| Float | 836.24M |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Leadership (GRFS)
GRFS is led by Jose Ignacio Abia Buenache (age 57), CEO & Director, per Nexqual as of July 25, 2026 at 03:50 UTC.
| CEO & Director | Jose Ignacio Abia Buenache (age 57) |
|---|---|
| Chief Financial Officer | Rahul Srinivasan (age 48) |
| Senior Vice President of Strategy & COO Office | Lluis Pons Gomez (age 41) |
| Head of Investor Relations & Sustainability and Vice President | Daniel Segarra |
| President of Commercial Tech Support | Sergio Roura Adell (age 56) |
Major Backers & Investors (GRFS)
Notable institutional backers of GRFS include Brandes Investment Partners L.P., Capital Group, Permian Investment Partners, Lp, according to Nexqual as of July 25, 2026 at 03:50 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Brandes Investment Partners L.P. | 13.9% |
| Capital Group | 8.77% |
| Permian Investment Partners, Lp | 7.4% |
| NEW PERSPECTIVE FUND | 5.37% |
| Black Creek Investment Management Inc. | 3.21% |
| Datum One Series Trust-BRANDES INTERNATIONAL SMALL CAP EQUITY FUND | 2.29% |
| Intl Growth & Income Fd.-Intl Growth and Income Fd. | 1.98% |
| Millennium Management | 1.91% |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HCM | HUTCHMED (China) Limited | USD 11.01 | ▼ 0.99% |
| LIVN | LivaNova PLC | USD 78.19 | ▼ 0.1% |
| IRWD | Ironwood Pharmaceuticals, Inc. | USD 3.71 | ▼ 4.38% |
| LKFT | Lakefront Biotherapeutics | USD 27.84 | ▼ 3.27% |
| FMS | Fresenius Medical Care AG | USD 24.59 | ▲ 1.19% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:50 UTC. This page is informational and not investment advice.